Rizzardi PH, de Farias Gabriel A, Martins ID, Carrard VC, Zanella VG, Girardi FM, et al. Metastatic melanoma of the major salivary glands - a systematic review. Med Oral Patol Oral Cir Bucal. 2025 Sep 1;30 (5):e736-44.


doi:10.4317/medoral.27216

https://dx.doi.org/doi:10.4317/medoral.27216


1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-49.

https://doi.org/10.3322/caac.21660

PMid:33538338 

2. Damsky WE, Theodosakis N, Bosenberg M. Melanoma metastasis: new concepts and evolving paradigms. Oncogene. 2014;33:2413-22.

https://doi.org/10.1038/onc.2013.194

PMid:23728340 

3. Helsing P, Robsahm TE, Vos L, Rizvi SM, Akslen LA, Veierød MB. Cutaneous head and neck melanoma (CHNM): A population-based study of the prognostic impact of tumor location. J Am Acad Dermatol. 2016;75:975-82.e2.

https://doi.org/10.1016/j.jaad.2016.06.048

PMid:27546291 

4. Hoersch B, Leiter U, Garbe C. Is head and neck melanoma a distinct entity?. A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol. 2006;155:771-7.

https://doi.org/10.1111/j.1365-2133.2006.07455.x

PMid:16965427 

5. Scott JF, Thompson CL, Vyas R, Honda K, Zender C, Rezaee R, et al. Parotid melanoma of unknown primary. J Cancer Res Clin Oncol. 2016;142:1529-37.

https://doi.org/10.1007/s00432-016-2156-x

PMid:27075178 

6. Elshenawy Y, Youngberg G, Al-Abbadi MA. Unusual clinical presentation of cutaneous malignant melanoma metastatic to the parotid gland; initially discovered by fine needle aspiration: case report and review of literature. Diagn Cytopathol. 2011;39:373-6.

https://doi.org/10.1002/dc.21454

PMid:20949472 

7. Castellani G, Buccarelli M, Arasi MB, Rossi S, Pisanu ME, Bellenghi M, et al. BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. Cancers (Basel). 2023;15:4026.

https://doi.org/10.3390/cancers15164026

PMid:37627054 PMCid:PMC10452867

8. Clausen F, Poulsen H. Metastatic carcinoma of the jaws. Acta Pathol Microbiol Scand. 1963;57:361-74.

https://doi.org/10.1111/j.1699-0463.1963.tb05105.x

PMid:14064805 

9. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache. 2013;53:1541-7.

https://doi.org/10.1111/head.12246

PMid:24266334 

10. Saravakos P, Kourtidis S, Hartwein J, Preyer S. Parotid Gland Tumors: A Multicenter Analysis of 1020 Cases. Increasing Incidence of Warthin's Tumor. Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 2):2033-40.

https://doi.org/10.1007/s12070-020-01981-z

PMid:36452806 PMCid:PMC9702007

11. Bhatt AM, Mesa H, Chen S, Molden B, Hou T. FNA diagnosis of secondary malignancies in the parotid gland: over 20 years of experience from a single institute. J Am Soc Cytopathol. 2025;14:36-43.

https://doi.org/10.1016/j.jasc.2024.08.131

PMid:39322514 

12. Bron LP, Traynor SJ, McNeil EB, O'Brien CJ. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope. 2003;113:1070-5.

https://doi.org/10.1097/00005537-200306000-00029

PMid:12782825 

13. Gao N, Li LJ, Li Y, Wang L. Primary amelanotic malignant melanoma of the parotid gland: a case report. J Int Med Res. 2008;36:1435-39.

https://doi.org/10.1177/147323000803600633

PMid:19094455 

14. Franzen A, Buchali A, Lieder A. The rising incidence of parotid metastases: our experience from four decades of parotid gland surgery. Acta Otorhinolaryngol Ital. 2017;37:264-9.

https://doi.org/10.14639/0392-100X-1095

PMid:28872155 PMCid:PMC5584096

15. Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010;74:134-48.

https://doi.org/10.1016/j.critrevonc.2009.10.004

PMid:19939701 

16. Murali R, Thompson JF, Uren RF, Scolyer RA. Fine-needle biopsy of metastatic melanoma: clinical use and new applications. Lancet Oncol. 2010;11:391-400.

https://doi.org/10.1016/S1470-2045(09)70332-8

PMid:20106719 

17. Díaz KP, Gerhard R, Domingues RB, Martins LL, Prado Ribeiro AC, Lopes MA, et al. High diagnostic accuracy and reproducibility of fine-needle aspiration cytology for diagnosing salivary gland tumors: cytohistologic correlation in 182 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:226-35.

https://doi.org/10.1016/j.oooo.2014.04.004

PMid:24935698 

18. Singh AD, Wani FA, Bhardwaj S. Diagnostic accuracy of FNAC and cyto-histopathological correlation in testicular and paratesticular mass lesions. Cytopathology. 2017;28:542-8.

https://doi.org/10.1111/cyt.12456

PMid:28913933 

19. Xing Y, Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011;103:129-42.

https://doi.org/10.1093/jnci/djq455

PMid:21081714 PMCid:PMC3022618

20. Liu ZF, Sylivris A, Wu J, Tan D, Hong S, Lin L, et al. Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis. Am J Clin Dermatol. 2024;25:513-25.

https://doi.org/10.1007/s40257-024-00862-3

PMid:38635019 

21. Simonetti I, Trovato P, Granata V, Picone C, Fusco R, Setola SV, et al. Imaging Assessment of Interval Metastasis from Melanoma. J Pers Med. 2022 Jun 24;12:1033.

https://doi.org/10.3390/jpm12071033

PMid:35887530 PMCid:PMC9315548

22. Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol. 2017;112:136-52.

https://doi.org/10.1016/j.critrevonc.2017.01.019

PMid:28325255 

23. López F, Rodrigo JP, Cardesa A, Triantafyllou A, Devaney KO, Mendenhall WM, et al. Update on primary head and neck mucosal melanoma. Head Neck. 2016;38:147-55.

https://doi.org/10.1002/hed.23872

PMid:25242350 PMCid:PMC4986507

24. Gong HZ, Zheng HY, Li J. Amelanotic melanoma. Melanoma Res. 2019;29:221-30.

https://doi.org/10.1097/CMR.0000000000000571

PMid:30672881 

25. Ordóñez NG. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update. Hum Pathol. 2014;45:191-205.

https://doi.org/10.1016/j.humpath.2013.02.007

PMid:23648379 

26. Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW. Immunohistochemical characteristics of melanoma. J Cutan Pathol. 2008;35:433-44.

https://doi.org/10.1111/j.1600-0560.2007.00891.x

PMid:18399807 

27. Wertz AP, Durham AB, Malloy KM, Johnson TM, Bradford CR, McLean SA. Total versus superficial parotidectomy for stage III melanoma. Head Neck. 2017;39:1665-70.

https://doi.org/10.1002/hed.24810

PMid:28481438 

28. Domingues B, Lopes JM, Soares P, Pópulo H. Melanoma treatment in review. Immunotargets Ther. 2018;7:35-49.

https://doi.org/10.2147/ITT.S134842

PMid:29922629 PMCid:PMC5995433

29. Alqathama A. BRAF in malignant melanoma progression and metastasis: potentials and challenges. Am J Cancer Res. 2020;10:1103-14.

PMid:32368388

30. Kestel S, Uyar Göçün FP, Öğüt B, Erdem Ö. Metastatic melanoma: clinicopathologic features and overall survival comparison. Acta Dermatovenerol Alp Pannonica Adriat. 2022;31:93-100.

https://doi.org/10.15570/actaapa.2022.14

PMid:36149038 

31. Cherobin ACFP, Wainstein AJA, Colosimo EA, Goulart EMA, Bittencourt FV. Prognostic factors for metastasis in cutaneous melanoma. An Bras Dermatol. 2018;93:19-26.

https://doi.org/10.1590/abd1806-4841.20184779

PMid:29641692 PMCid:PMC5871357

32. Ogata D, Namikawa K, Takahashi A, Yamazaki N. A review of the AJCC melanoma staging system in the TNM classification (eighth edition). Jpn J Clin Oncol. 2021;51:671-4.

https://doi.org/10.1093/jjco/hyab022

PMid:33709104 

33. Bunnell AM, Nedrud SM, Fernandes RP. Classification and Staging of Melanoma in the Head and Neck. Oral Maxillofac Surg Clin North Am. 2022;34:221-34.

https://doi.org/10.1016/j.coms.2021.12.001

PMid:35491079 

34. Eddy K, Shah R, Chen S. Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities. Front Oncol. 2021;10:626129.

https://doi.org/10.3389/fonc.2020.626129

PMid:33614507 PMCid:PMC7891057

35. Luan H, Jian L, He Y, Zhang T, Zhou L. Exploration and validation of metastasis-associated genes for skin cutaneous melanoma. Sci Rep. 2022;12:13002.

https://doi.org/10.1038/s41598-022-17468-6

PMid:35906389 PMCid:PMC9338051

36. Mimica X, McGill M, Hay A, Karassawa Zanoni D, Shah JP, Wong RJ, et al. Distant metastasis of salivary gland cancer: Incidence, management, and outcomes. Cancer. 2020;126:2153-62.

https://doi.org/10.1002/cncr.32792

PMid:32097509 PMCid:PMC8224983

37. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

https://doi.org/10.1136/bmj.n71

PMid:33782057 PMCid:PMC8005924